Andreas Halvorsen’s Editas Medicine EDIT Stock Holding History

Andreas Halvorsen’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-413,000	Closed	-$12.2M	–	90
2020 Q2	$12.2M	Sell	413,000 -99,179	-19%	-$2.59M	0.05%	69
2020 Q1	$10.2M	Sell	512,179 -221,222	-30%	-$5.58M	0.05%	61
2019 Q4	$21.7M	Hold	733,401	–	–	0.1%	62
2019 Q3	$16.7M	Sell	733,401 -198,000	-21%	-$4.9M	0.09%	58
2019 Q2	$23M	Hold	931,401	–	–	0.1%	58
2019 Q1	$22.8M	Hold	931,401	–	–	0.13%	54
2018 Q4	$21.2M	Hold	931,401	–	–	0.12%	53
2018 Q3	$29.6M	Hold	931,401	–	–	0.16%	55
2018 Q2	$33.4M	Sell	931,401 -103,903	-10%	-$3.68M	0.19%	54
2018 Q1	$34.3M	Sell	1,035,304 -674,097	-39%	-$24M	0.21%	51
2017 Q4	$52.5M	Hold	1,709,401	–	–	0.32%	45
2017 Q3	$41M	Hold	1,709,401	–	–	0.27%	51
2017 Q2	$28.7M	Hold	1,709,401	–	–	0.19%	50
2017 Q1	$38.2M	Hold	1,709,401	–	–	0.17%	54
2016 Q4	$27.7M	Hold	1,709,401	–	–	0.13%	59
2016 Q3	$23M	Hold	1,709,401	–	–	0.1%	58
2016 Q2	$41.7M	Sell	1,709,401 -426,122	-20%	-$14.4M	0.18%	51
2016 Q1	$73.8M	Buy	+2,135,523	New	+$56.1M	0.32%	42

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Andreas Halvorsen's EDIT Position: Q3 2020 in Review

Andreas Halvorsen sold out of Editas Medicine (EDIT) in Q3 2020, closing a stake of 413,000 shares — an estimated $12.2M sold.

Andreas Halvorsen first reported a position in EDIT in Q1 2016 and held it in 18 quarters. The position peaked at $73.8M in Q1 2016. 239 funds tracked by Wall St. Rank hold EDIT as of Q3 2020.

Andreas Halvorsen reported no remaining Editas Medicine position as of Q3 2020 after selling out during the quarter.
Andreas Halvorsen sold 413,000 Editas Medicine shares in Q3 2020, an estimated $12.2M.
Andreas Halvorsen first reported a position in Editas Medicine in Q1 2016 and held it in 18 quarters.
Andreas Halvorsen's Editas Medicine position peaked at $73.8M in Q1 2016.
239 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2020.

Based on Viking Global Investors's 13F filing for Q3 2020, filed 16 Nov 2020.